Evidence map›Paper›PMID 30468563›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2019

Repeat kidney transplant recipients with active rejection have elevated donor-derived cell-free DNA.

Shikha G Mehta, Jae H Chang, Tarek Alhamad, Jonathan S Bromberg, David J Hiller, Marica Grskovic, James P Yee, Roslyn B Mannon

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Emerging role of cell-free DNA in kidney transplantation.World journal of experimental medicine · 2021
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shikha G MehtaDivision of Nephrology, Department of Medicine, University of Alabama School of Medicine, Birmingham, Alabama.
Jae H ChangColumbia University Medical Center, New York, New York.
Tarek AlhamadWashington University, St. Louis, Missouri.ORCID 0000-0003-4289-0817
Jonathan S BrombergDivision of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
David J HillerCareDx, Brisbane, California.
Marica GrskovicCareDx, Brisbane, California.
James P YeeCareDx, Brisbane, California.
Roslyn B MannonDivision of Nephrology, Department of Medicine, University of Alabama School of Medicine, Birmingham, Alabama.ORCID 0000-0003-1776-3680

Funding

CareDx
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell-Free Nucleic AcidsGraft RejectionGraft SurvivalHumansIsoantibodiesKidney TransplantationPrognosisTissue DonorsTransplant RecipientsCell-Free Nucleic AcidsIsoantibodiesacuteantibody-mediated (ABMR)clinical research/practiceimmunekidney transplantation/nephrologymonitoringrejection

Identifiers

PMID30468563
PMCPMC6587949

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.